Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give combinations of three or four anti-HIV drugs to HIV-infected patients. The drugs used in this study are delavirdine (DLV), nelfinavir (NLF), didanosine (ddI), and stavudine (d4T).

Key facts

Study ID

NCT00002211

Run by

Pharmacia and Upjohn

People needed

160

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You may be eligible for this study if you:
• Are at least 18 years old.
• Are HIV-positive.
• Have a CD4 count of at least 50 cells/mm3.
• Have a viral load of at least 20,000 copies/ml.

You may not qualify if…

• You will not be eligible for this study if you:
• Have taken d4T.
• Have taken protease inhibitors, including NFV.
• Have taken nonnucleoside reverse transcriptase inhibitors.
• Have taken ddI for 1 month or more.

Where it is running

• Pharmacia & Upjohn — Peapack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.